fda approval for semaglutide Approves Oral as the First Oral GLP-1 Pill Novo Nordisk's weight-loss pill wins
Description
doi: 10.1038/nm.3372
S2CID 6471940

The weight curve had not plateaued at 48 weeks, which suggests the ceiling sits beyond the trial window

Diabetes Care 44(Suppl 1):S211S220
